CVS Caremark intends to institute a $100,000 per QALY threshold for drugs, above which it would deny patient access. However, without an empirically determined threshold, pricing and formulary decisions contingent on an arbitrarily defined threshold cannot be considered value-based.
Will CVS Caremark Make ICER The American NICE?
